CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 47 enrolled
Drug / intervention
Morphine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00761085
NCT00761085N/ACompleted
CompareCT.gov

Methadone in Pediatric and Adult Sickle Cell Patients

Washington University School of Medicine·interventional·Posted Sep 26, 2008·Updated Jan 22, 2020

In Brief

A clinical study evaluating Morphine and Methadone for Sickle Cell Disease. Completed, enrolled 47 participants across 1 site.

Detailed Summary

To determine the pharmacokinetics of methadone in children and adults with SCD who are experiencing a painful episode.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSickle Cell Disease
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 26, 2008
Enrollment StartJan 1, 2008
Primary CompletionNov 7, 2010
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 17.8 years ago

Interventions

Morphinedrug

Standard of care for pain management of acute episode of pain

Methadonedrug

Compare to standard of care for pain management of acute episode of pain